← back to database
Taiho Ventures is the corporate venture arm of Taiho Pharmaceutical, investing globally in drug-discovery companies, therapeutic platforms, and pipeline spinouts. It focuses on oncology and selected immunology, allergy, bone, muscle, and orphan-disease programs, with opportunistic medical-device, diagnostics, and digital-health investments.
Stage focus
Lead / follow
Specialization
Generalist / Specialist
Specialist
Latest fund size
$400 million corporate investment pool (evergreen)
Investing team
Hidefumi KasugaInvestment Director
- Sakae AsanumaPresident & CEO
- Seiji MiyaharaPartner & Senior Investment Director
- Takaaki IshiiSenior Investment Director
Takayuki HiranoAssociate Investment Director